For the vast majority of patients, a metered dose inhaler is the preferred therapy. Nebulizer therapy will be reimbursed for patients who are unable to use a metered dose inhaler, including an inhaler with a spacer attachment, or a turbuhaler.
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have a tracheostomy;
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and be patients with cystic fibrosis in whom nebulizer therapy is indicated;.
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;
Individuals must have a known hypersensitivity to the preservative in the bulk solution, and have severe mental or physical disabilities;
Patients who have previously used nebulizer therapy within the last 12 month period.
Patients who have previously used nebulizer therapy within the last 12 month period.